Search Results - "Spinaci, Andrea"
-
1
Combined Therapy of A1AR Agonists and A2AAR Antagonists in Neuroinflammation
Published in Molecules (Basel, Switzerland) (23-02-2021)“…Alzheimer’s, Parkinson’s, and multiple sclerosis are neurodegenerative diseases related by neuronal degeneration and death in specific areas of the central…”
Get full text
Journal Article -
2
P2X3 Receptor Ligands: Structural Features and Potential Therapeutic Applications
Published in Frontiers in pharmacology (13-04-2021)Get full text
Journal Article -
3
Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A2A Adenosine Receptor Useful in Neurodegenerative Disorders
Published in Molecules (Basel, Switzerland) (14-06-2023)“…Currently, the number of patients with neurodegenerative pathologies is estimated at over one million, with consequences also on the economic level. Several…”
Get full text
Journal Article -
4
A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?
Published in Molecules (Basel, Switzerland) (07-04-2022)“…The A2A adenosine receptor (A2AAR) is one of the four subtypes activated by nucleoside adenosine, and the molecules able to selectively counteract its action…”
Get full text
Journal Article -
5
The G Protein-Coupled Receptor GPR17: Overview and Update
Published in ChemMedChem (06-12-2016)“…The GPR17 receptor is a G protein‐coupled receptor (GPCR) that seems to respond to two unrelated families of endogenous ligands: nucleotide sugars (UDP,…”
Get full text
Journal Article -
6
Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 Delta
Published in Pharmaceuticals (Basel, Switzerland) (01-04-2024)“…Protein kinase CK1δ (CK1δ) is a serine-threonine/kinase that modulates different physiological processes, including the cell cycle, DNA repair, and apoptosis…”
Get full text
Journal Article -
7
A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
Published in Pharmaceuticals (Basel, Switzerland) (28-01-2022)“…The overexpression of the A3 adenosine receptor (AR) in a number of cancer cell types makes it an attractive target for tumor diagnosis and therapy. Hence, in…”
Get full text
Journal Article -
8
Adenosine receptors as neuroinflammation modulators: role of A1 agonists and A2A antagonists
Published in Cells (Basel, Switzerland) (21-07-2020)“…© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative…”
Get full text
Journal Article -
9
“Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies
Published in Pharmaceuticals (Basel, Switzerland) (23-01-2023)“…Based on a screening of a chemical library of A2A adenosine receptor (AR) antagonists, a series of di- and tri-substituted adenine derivatives were synthesized…”
Get full text
Journal Article -
10
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview
Published in Pharmaceuticals (Basel, Switzerland) (08-10-2019)“…Potent and selective adenosine receptor (AR) agonists are of pharmacological interest for the treatment of a wide range of diseases and conditions. Among these…”
Get full text
Journal Article -
11
The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis
Published in Cells (Basel, Switzerland) (21-06-2020)“…The pharmacological activation of A3 receptors has shown potential usefulness in the management of bowel inflammation. However, the role of these receptors in…”
Get full text
Journal Article -
12
Multipotent Stromal Cells from Subcutaneous Adipose Tissue of Normal Weight and Obese Subjects: Modulation of Their Adipogenic Differentiation by Adenosine A1 Receptor Ligands
Published in Cells (Basel, Switzerland) (17-12-2021)“…Adenosine A1 receptor (A1R) activation, stimulating lipogenesis and decreasing insulin resistance, could be useful for metabolic syndrome management in obese…”
Get full text
Journal Article -
13
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications
Published in Expert opinion on therapeutic patents (02-12-2019)“…: Purinergic P2X3-P2X2/3 receptors are placed in nociceptive neurons' strategic location and show unique desensitization properties; hence, they represent an…”
Get more information
Journal Article -
14
A patent review of adenosine A 2B receptor antagonists (2016-present)
Published in Expert opinion on therapeutic patents (03-06-2022)“…A adenosine receptor (A AR) plays a crucial role in pathophysiologic conditions associated with high adenosine release, typical of airway inflammatory…”
Get more information
Journal Article -
15
Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A[sub.2A] Adenosine Receptor Useful in Neurodegenerative Disorders
Published in Molecules (Basel, Switzerland) (01-06-2023)“…Currently, the number of patients with neurodegenerative pathologies is estimated at over one million, with consequences also on the economic level. Several…”
Get full text
Journal Article -
16
Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity
Published in Journal of medicinal chemistry (08-08-2019)“…A new series of amino-3,5-dicyanopyridines (1–31) was synthesized and biologically evaluated in order to further investigate the potential of this scaffold to…”
Get full text
Journal Article -
17
A 3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
Published in Pharmaceuticals (Basel, Switzerland) (28-01-2022)“…The overexpression of the A adenosine receptor (AR) in a number of cancer cell types makes it an attractive target for tumor diagnosis and therapy. Hence, in…”
Get full text
Journal Article -
18
New potent and selective A1 adenosine receptor antagonists as potential tools for the treatment of gastrointestinal diseases
Published in European journal of medicinal chemistry (10-05-2018)“…The synthesis of 9-alkyl substituted adenine derivatives presenting aromatic groups and cycloalkyl rings in 8- and N6-position, respectively, is reported. The…”
Get full text
Journal Article -
19
Adenine derivatives as inhibitors of the casein kinase CK1delta enzyme
Published in Medicinal chemistry research (01-04-2024)“…Overexpression of CK1δ has been associated to the development of cancer and neurodegenerative disorders, making ligands of this protein very promising drug…”
Get full text
Journal Article -
20
“Dual Anta-Inhibitors” of the A[sub.2A] Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies
Published in Pharmaceuticals (Basel, Switzerland) (01-01-2023)“…Based on a screening of a chemical library of A[sub.2A] adenosine receptor (AR) antagonists, a series of di- and tri-substituted adenine derivatives were…”
Get full text
Journal Article